Kimura Nana, Igarashi Takamichi, Murotani Kenta, Itoh Ayaka, Watanabe Toru, Hirano Katsuhisa, Tanaka Haruyoshi, Shibuya Kazuto, Yoshioka Isaku, Fujii Tsutomu
Department of Surgery and Science, Faculty of Medicine, Academic Assembly University of Toyama Toyama Japan.
Biostatistics Center, Graduate School of Medicine Kurume University Kurume Japan.
Ann Gastroenterol Surg. 2023 Sep 28;8(2):301-311. doi: 10.1002/ags3.12744. eCollection 2024 Mar.
There have been few studies of countermeasures against postoperative cholangitis, a serious complication after pancreaticoduodenectomy (PD) that impairs quality of life.
To evaluate our recently developed, novel method of choledochojejunostomy with a larger anastomotic diameter, the "T-shaped anastomosis."
The study included 261 cases of PD. The T-shaped choledochojejunostomy technique was performed with an additional incision for a distance greater than half the diameter of the bile duct at the anterior wall of the bile duct and the anterior wall of the elevated jejunum. To compensate for potential confounding biases between the standard anastomosis group ( = 206) and the T-shaped anastomosis group ( = 55), we performed propensity score matching (PSM). The primary endpoint was the incidence of medium-term postoperative cholangitis adjusted for PSM.
In the PSM analysis, 54 patients in each group were matched, and the median bile duct diameter measured by preoperative CT was 8.8 mm versus 9.3 mm, the rate of preoperative biliary drainage was 31% versus 37%, the incidence of cholangitis within 1 month before surgery was 9% versus 13%, and the incidence of postoperative bile leakage was 2% versus 2%, with no significant differences. The incidence of medium-term postoperative cholangitis was 15% versus 4%, and multivariate logistic regression revealed that T-shaped choledochojejunostomy was an independent predictor of a reduced incidence of cholangitis (odds ratio, 0.17, 95% CI 0.02-0.81; = 0.024).
The T-shaped choledochojejunostomy technique was shown to be effective with a significant reduction in the incidence of medium-term postoperative cholangitis. Clinical trial identification: UMIN000050990.
针对术后胆管炎的对策研究较少,术后胆管炎是胰十二指肠切除术(PD)后一种严重的并发症,会损害生活质量。
评估我们最近开发的一种新型胆总管空肠吻合术,即“T形吻合术”,其吻合口直径更大。
该研究纳入了261例PD患者。T形胆总管空肠吻合术是在胆总管前壁和空肠升支前壁额外切开一段距离,该距离大于胆管直径的一半。为了弥补标准吻合术组(n = 206)和T形吻合术组(n = 55)之间潜在的混杂偏倚,我们进行了倾向评分匹配(PSM)。主要终点是经PSM调整后的术后中期胆管炎发病率。
在PSM分析中,每组匹配了54例患者,术前CT测量的中位胆管直径分别为8.8 mm和9.3 mm,术前胆道引流率分别为31%和37%,术前1个月内胆管炎发病率分别为9%和13%,术后胆漏发生率分别为2%和2%,差异均无统计学意义。术后中期胆管炎发病率分别为15%和4%,多因素logistic回归显示,T形胆总管空肠吻合术是胆管炎发病率降低的独立预测因素(比值比,0.17,95%CI 0.02 - 0.81;P = 0.024)。
T形胆总管空肠吻合术被证明是有效的,可显著降低术后中期胆管炎的发病率。临床试验注册号:UMIN000050990。